Arizona cannabis sales stats are down for the second straight year in a row, and have taken enough of a dip that the Arizona Mirror described medical marijuana sales as “cratering” and recreational sales as “softening.” According to sales figures from the state Department of Revenue, annual sales are down …
Missouri revokes 25 cannabis licenses in social equity program crackdown
Missouri cannabis regulators revoked 25 more microbusiness licenses after concluding the operations wouldn’t be genuinely controlled by the disadvantaged entrepreneurs the program was designed to help, the Missouri Independent reported. The action brings to 34 the number of licenses canceled by the state since the social equity program launched in …
NORML Op-Ed: Marijuana Legalization Advocates Are the Majority. It’s Time to Act Like It
Regardless of whether you live in a red or blue state, or in a jurisdiction where cannabis is legal or illicit, it’s time for legalization advocates to stand up and assert themselves. The post NORML Op-Ed: Marijuana Legalization Advocates Are the Majority. It’s Time to Act Like It appeared first on NORML.
Psyence BioMed invests $500,000 more into PsyLabs, locks down Ibogaine supply deal
Psyence Biomedical (NASDAQ: PBM) invested an additional $500,000 in PsyLabs, deepening its relationship with the psychedelic ingredients producer while securing exclusive access to pharmaceutical-grade ibogaine. The cash infusion builds on Psyence’s initial partnership from September 2024, when it acquired an 11.13% equity stake in PsyLabs and locked down exclusive rights …